SARA HASENBEIN: Open Payments
NPI 1346752490 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$515 in 28 payments from 9 companies in 2025. Trend: 2023 $788 · 2024 $863 · 2025 $515
Food & beverage: $515
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 16 | $271 |
| Lilly USA, LLC | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Stryker Corporation | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
Products named: LifeVest, Kerendia, Ozempic, JARDIANCE, GVOKE HYPOPEN, MOUNJARO, FLOWTRIEVER, ZORYVE.
Industry payments across AL — which companies pay providers there.
